BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9061569)

  • 1. Progression of X-linked adrenoleukodystrophy under interferon-beta therapy.
    Korenke GC; Christen HJ; Kruse B; Hunneman DH; Hanefeld F
    J Inherit Metab Dis; 1997 Mar; 20(1):59-66. PubMed ID: 9061569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoleukodystrophy in a Chinese boy.
    Wong V
    Brain Dev; 1992 Jul; 14(4):276-7. PubMed ID: 1279999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
    Khan M; Pahan K; Singh AK; Singh I
    J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Lorenzo's oil on oxidative stress in X-linked adrenoleukodystrophy.
    Deon M; Wajner M; Sirtori LR; Fitarelli D; Coelho DM; Sitta A; Barschak AG; Ferreira GC; Haeser A; Giugliani R; Vargas CR
    J Neurol Sci; 2006 Sep; 247(2):157-64. PubMed ID: 16750542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin therapy for X-linked adrenoleukodystrophy: clinical and biochemical observations on 12 patients.
    Pai GS; Khan M; Barbosa E; Key LL; Craver JR; Curé JK; Betros R; Singh I
    Mol Genet Metab; 2000 Apr; 69(4):312-22. PubMed ID: 10870849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excessive production of tumour necrosis factor alpha by peripheral blood mononuclear cells in X-linked adrenoleukodystrophy.
    Lannuzel A; Aubourg P; Tardieu M
    Eur J Paediatr Neurol; 1998; 2(1):27-32. PubMed ID: 10726843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".
    van Geel BM; Assies J; Haverkort EB; Koelman JH; Verbeeten B; Wanders RJ; Barth PG
    J Neurol Neurosurg Psychiatry; 1999 Sep; 67(3):290-9. PubMed ID: 10449548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock protein expression in cerebral X-linked adrenoleukodystrophy reveals astrocyte stress prior to myelin loss.
    Görtz AL; Peferoen LAN; Gerritsen WH; van Noort JM; Bugiani M; Amor S
    Neuropathol Appl Neurobiol; 2018 Jun; 44(4):363-376. PubMed ID: 28319253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice.
    Netik A; Hobel A; Rauschka H; Molzer B; Forss-Petter S; Berger J
    J Inherit Metab Dis; 2000 Sep; 23(6):615-24. PubMed ID: 11032336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual evoked potentials in adrenoleukodystrophy: a trial with glycerol trioleate and Lorenzo oil.
    Kaplan PW; Tusa RJ; Shankroff J; Heller J; Moser HW
    Ann Neurol; 1993 Aug; 34(2):169-74. PubMed ID: 8338341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral inflammation in X-linked adrenoleukodystrophy.
    McGuinness MC; Smith KD
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):281-7. PubMed ID: 10604233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton MR spectroscopic imaging predicts lesion progression on MRI in X-linked adrenoleukodystrophy.
    Eichler FS; Barker PB; Cox C; Edwin D; Ulug AM; Moser HW; Raymond GV
    Neurology; 2002 Mar; 58(6):901-7. PubMed ID: 11914405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of repeated cyclophosphamide pulse therapy in childhood cerebral X-linked adrenoleukodystrophy.
    Horvath GA; Eichler F; Poskitt K; Stockler-Ipsiroglu S
    Neuropediatrics; 2012 Feb; 43(1):48-52. PubMed ID: 22430161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy.
    van de Beek MC; Ofman R; Dijkstra I; Wijburg F; Engelen M; Wanders R; Kemp S
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2255-2265. PubMed ID: 28666219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
    Mosser J; Douar AM; Sarde CO; Kioschis P; Feil R; Moser H; Poustka AM; Mandel JL; Aubourg P
    Nature; 1993 Feb; 361(6414):726-30. PubMed ID: 8441467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic plasma exchange in treatment of adrenoleukodystrophy.
    Bambauer R; Schiel R; Cordes H; Latza R
    Ther Apher; 2000 Oct; 4(5):338-41. PubMed ID: 11111814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.